ADCVX
Price
$18.11
Change
-$0.79 (-4.18%)
Updated
Apr 10 closing price
Net Assets
370.31M
GFACX
Price
$57.41
Change
+$0.90 (+1.59%)
Updated
Apr 11 closing price
Net Assets
260.89B
Ad is loading...

ADCVX vs GFACX

Header iconADCVX vs GFACX Comparison
Open Charts ADCVX vs GFACXBanner chart's image
American Century Disciplined Growth A
Price$18.11
Change-$0.79 (-4.18%)
VolumeN/A
Net Assets370.31M
American Funds Growth Fund of Amer C
Price$57.41
Change+$0.90 (+1.59%)
VolumeN/A
Net Assets260.89B
ADCVX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ADCVX vs. GFACX commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCVX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 261B vs. ADCVX (370M). ADCVX (0.00) and GFACX (0.00) have matching dividends . ADCVX was incepted earlier than GFACX: ADCVX (20 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than ADCVX (1.26). ADCVX is a more actively managed with annual turnover of: 40.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than ADCVX: GFACX (250) vs ADCVX (2500). GFACX annual gain was more profitable for investors over the last year : -3.95 vs. ADCVX (-26.72). GFACX return over 5 years is better than : 40.74 vs. ADCVX (-6.09).
ADCVXGFACXADCVX / GFACX
Total Expense Ratio1.171.3686%
Annual Report Gross Expense Ratio1.261.3693%
Fund Existence20 years24 years-
Gain YTD-11.268-7.732146%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets370M261B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-26.72-3.95676%
Returns for 3 years-8.944.35-206%
Returns for 5 years-6.0940.74-15%
Returns for 10 years-1.8338.82-5%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings